| Date | Title | Description | Source |
| 12.03.2024 | X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 20... | - | globenewsw... |
| 30.01.2024 | COUR Pharmaceuticals Secures $105 Million in Series A Financ... | - | globenewsw... |
| 03.08.2023 | X4 Pharmaceuticals Closes $115 Million Loan Facility with He... | - | globenewsw... |
| 03.08.2023 | X4 Pharmaceuticals Closes $115 Million Loan Facility with He... | - | orbimed.co... |
| 26.09.2022 | DAMONA Pharmaceuticals Raises US$5.5 Million Seed Stage Fina... | TORONTO, Ontario, September 26, 2022 — DAMONA Pharmaceuticals today announced the closing of a seed ... | lumiravent... |
| 26.07.2022 | X4 Pharmaceuticals Announces $55 Million Private Placement F... | X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4 ta... | lumiravent... |
| 20.01.2022 | China SXT Pharmaceuticals, Inc. Announces Successful Closing... | TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" ... | marketscre... |
| 20.01.2022 | China SXT Pharmaceuticals, Inc. Announces Successful Closing... | TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" ... | globenewsw... |
| 09.11.2021 | ANI Pharmaceuticals, Inc. Announces Closing of $75 Million P... | ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (ANI or the Company) today announced the closing of its pre... | marketscre... |
| 04.11.2021 | ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million P... | ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (“ANI” or the "Company") today announced the pric... | marketscre... |
| 03.11.2021 | NovaBay Pharmaceuticals, Inc. Closes $15.0 Million Private P... | NovaBay Pharmaceuticals, Inc. announced the closing of a previously announced private placement for ... | marketscre... |
| 19.03.2021 | X4 Pharmaceuticals Announces $55.0 Million At-the-Market Pri... | - | orbimed.co... |
| 17.11.2017 | Term Sheet — Friday, November 17 | THE ULTIMATE BUSINESS BOOK LIST
Good morning, Term Sheet readers.
Paid Content How can you protect w... | fortune.co... |
| 16.11.2017 | X4 Pharmaceuticals Secures $27M in Series B Financing | X4 Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company developing novel CXCR... | finsmes.co... |
| 14.12.2015 | Daily funding roundup - December 14, 2015 | RiverMend Health secured $60M; X4 Pharmaceuticals bagged $37.5M; MST3K Kickstarter raised $5.76M
Mis... | vator.tv/n... |
| 14.12.2015 | X4 Pharmaceuticals Raises $37.5M in Series A Financing | X4 Pharmaceuticals, a Cambridge, Mass.-based clinical stage biotechnology company, raised $37.5m in ... | finsmes.co... |
| 14.12.2015 | Genzyme spinout X4 Pharmaceuticals lays out clinical plan | Unsurprisingly, the company is backed by Henri Termeer, the former chairman, president and CEO of Ge... | medcitynew... |
| 03.03.2015 | Vascular Pharmaceuticals, Inc. Completes $9.0 Million Expans... | CHAPEL HILL, N.C., March 5, 2015 –Vascular Pharmaceuticals, Inc. (VPI), a clinical-stage pharmaceuti... | lumiravent... |
| - | Genzyme spinout X4 Pharmaceuticals lays out clinical plan | X4 Pharmaceuticals, a Cambridge startup with deep ties to Genzyme, has laid out its clinical develop... | medcitynew... |
